SwissEdilab has sold the brands Colon Pure & Ail Noir Oxyprotect to Noreva Pharma
SwissEdilab, a firm specialized in distribution of food supplements, has sold the brands Colon Pure and Ail Noir Oxyprotect to Noreva Pharma.
Noreva Pharma is a French cosmetics laboratory specialized in the development of dermatological care products distributed in drug stores.
This strategic acquisition expands the firm's product range distributed by its sales force. Noreva Pharma, which is very active in the OTC health market in France, had already acquired Phythea in 2016 and the Bergasol brand from Omega Pharma in 2018.
Oaklins' team in France was the sell-side advisor for SwissEdilab in this transaction.
Talk to the deal team
Related deals
Armira has signed an agreement to acquire a majority stake in Viabus
Armira, a Germany-based investment firm, has signed an agreement to acquire a majority stake in Viabus, a leading Dutch tour operator focused on senior and young senior travelers.
Learn moreTheNativeFoods has sold a 60% majority stake to investors led by HCapital Partners
TheNativeFoods has entered a new growth phase following the sale of a 60% stake to HCapital Partners, alongside PCL Investments and Premium Peculi. The founding shareholder retains a 40% interest and will continue to lead the company as CEO to ensure a smooth transition and sustained expansion.
Learn moreEasy-Barf has been acquired by The Nutriment Company
Easy-BARF, a French fresh pet food manufacturer, has been acquired by The Nutriment Company. This transaction gives The Nutriment Company a strong position in France, Europe’s third-largest pet food market, and represents the company’s eighth acquisition in 2025.
Learn more